requires [M+Na, 740.19]+; found [C13H7BrNOS(C2H4O)8
67.20, 59.10, 58.59, 58.36, 58.18, 57.86, 57.62, 52.56, 36.68, 31.08.
HRMS-ESI: High resolution MS shows a series of ions centered
around m/z 2246 [C51H40N2O6S2(C2H4O)32C2H6 - CH3O]+ which
are fragments related to the various ethoxylate oligomers that
differ by Dm/z 44, an ethoxy unit.
CH3+Na]+ = 696.16, requires [M+Na, 696.17]+.
Synthesis of 2-[2-(polyethyleneglycol-550-monomethylether-1-
yl)-4- vinylphenyl)benzo[d]thiazole (D). Compound C (3 g,
3.94 mmol), Pd(dppf)Cl2·CH2Cl2 (0.32 g, 0.39 mmol), and CuI
(0.15 g, 0.78 mmol) were transferred to a high pressure Schlenk
tube, followed by addition of THF (50 mL) and tributyl(vinyl)tin
(1.62 g, 5.12 mmol). The Schlenk tube was sealed and stirred at
Synthesis of fluorene-RGD conjugate (2). Fluorene 1 (38 mg,
0.017 mmol) was dissolved in 2 mL H2O. After adjust-
ing the pH to 5.0–5.5 with 0.1 N NaOH (aq), sodium
N-hydroxysulfonosuccinimide (5 mg, 0.023 mmol) and 1-(3-
dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (6 mg,
0.026 mmol) were added. After stirring at 4 ◦C for 30 min, the
pH of the reaction mixture was adjusted to 9 with 0.1 N NaOH
(aq) and c(RGDfK) (10 mg, 0.016 mmol), dissolved in 0.5 mL of
0.1 M Na2HPO4 solution (pH = 9), was added. The reaction was
stirred at room temperature for 24 h. Water was removed under
reduced pressure, providing yellow oil, which was redissolved in
CH2Cl2, dried over NaSO4, filtered, and concentrated. The oil was
washed several times with ether, then dried to afford 2 (43 mg,
◦
90 C. After 96 h, silica gel TLC indicated disappearance of the
aryl bromide. Hence, the dark brown reaction mixture was cooled
to room temperature, diluted CH2Cl2, and filtered through a plug
of silica gel. The crude product was concentrated and purified
by column chromatography on silica gel using ethyl acetate–
MeOH (4 : 1) providing D (2.1 g, 71%) as colorless oil. 1H NMR
(500 MHz, CDCl3) d: 8.48 (d, J = 8.5 Hz, 1H), 8.06 (d, J =
6 Hz, 1H), 7.91 (d, J = 8 Hz, 1H), 7.48 (t, J = 15 Hz, 1H),
7.36 (t, J = 14.5 Hz,1H), 7.17 (d, J = 8 Hz, 1H), 7.07 (s, 1H),
6.74 (q, J = 17.5 Hz, 1H), 5.86 (d, J = 17.5 Hz, 1H), 5.36 (d,
J = 10.5 Hz, 1H), 4.40 (t, J = 10 Hz, 2H), 4.07 (t, J = 10 Hz,
2H), 3.79 (t, J = 9 Hz, 2H), 3.69-3.51 (m, 59H), 3.35 (s, 3H).13C
NMR (125 MHz, CDCl3) d: 162.87, 156.62, 152.01, 141.04,
136.19, 136.10, 136.12, 129.71, 129.55, 126.0, 125.74, 124.66,
124.43, 122.66, 121.22, 119.44, 119.22, 110.38, 110.18, 71.88,
70.85, 70.65, 70.60, 70.48, 70.34, 69.69, 69.53, 69.35, 68.44, 59.01,
1
90%) as a yellow oil. H NMR (500 MHz, d-DMSO) d: 8.55 (d,
J = 8 Hz, 2H), 8.09 (d, J = 8 Hz, 2H), 7.94 (d, J = 8 Hz, 2H),
7.67 (d, J = 8 Hz, 2H), 7.60 (s, 2H), 7.52-7.17 (m, 5H), 7.50 (t,
J = 8 Hz, 3H), 7.38-7.09 (m, 15H), 4.47 (t, J = 10 Hz, 5H),
4.12 (t, J = 9.5 Hz, 5H), 3.84 -3.52 (m, 118 H), 3.36 (s, 6H),
3.31-3.10 (m, 10H), 2.83 (t, 15.5 Hz, 2H), 2.74 (bt, 1H), 2.53-2.42
(m,6H), 1.74 (s, 1H), 1.63 (t, 16 Hz, 3H), 1.24 (s, 3H).13C NMR
(125 MHz, CDCl3) d: 175.48, 171.27, 168.48, 162.88, 159.99,
159.81, 156.71, 152.10, 152.12, 149.33, 140.97, 140.55, 136.41,
136.12, 136.10, 129.89, 129.64, 126.14, 125.80, 122.68, 122.53,
121.58, 121.26, 120.81, 119.32, 110.13, 71.83, 71.67, 71.25, 70.84,
70.67, 70.55, 70.43, 70.18, 69.94, 69.54, 69.39, 69.03, 68.48, 58.98,
56.42, 55.81, 55.56, 55.30, 54.99, 54.73, 52.18, 45.95, 44.25, 43.59,
43.19, 42.77, 42.38, 36.96, 36.87, 36.37, 36.29, 36.20, 35.81, 35.63,
35.23, 34.96, 34.70, 34.40, 34.12, 30.50, 29.67, 28.55, 25.81, 25.67,
25.54, 16.49, 15.74, 15.59, 15.44, 15.29, 14.54. HRMS-ESI: High
resolution MS shows a series of ions centered around m/z 2246
[C78H79N11O12S2(C2H4O)30C2H6+Na]+ which are fragments related
to the various ethoxylate oligomers that differ by Dm/z 44, an
ethoxy unit.
58.98. HRMS-ESI: found [C15H10NOS(C2H4O)15CH3+Na]+
=
950.32, requires [M+Na, 950.41]+; found [C15H10NOS(C2H4O)14-
CH3+Na]+ = 906.38, requires [M+Na, 906.43]+; found [C15H10-
NOS(C2H4O)13CH3+Na]+ = 862.36, requires [M+Na, 862.4]+;
found [C15H10NOS(C2H4O)12CH3+Na]+
=
818.37, [M+Na,
818.38]+; found [C15H10NOS(C2H4O)11CH3+Na]+ = 774.34, re-
quires [M+Na, 774.35]+; [C15H10NOS(C2H4O)10CH3+Na]+
=
730.32, requires [M+Na, 730.32]+; found [C15H10NOS(C2H4O)9-
CH3+Na]+ = 686.29, requires [M+Na, 686.30]+.
Synthesis of 3-(9-(2-(2-methoxyethoxy)ethyl)-2,7-bis{3-[2-
(polyethyleneglycol-550-monomethylether-1-yl)]-4-(benzo[d]thi-
azol-2-yl)styryl}-9H-fluoren-9-yl)propanoic acid (1). 3-(9-(2-(2-
Methoxyethoxy)ethyl)-2,7-dibromo-9H -fluoren-9-l)propanoic
acid (E) (0.17 g, 0.34 mmol), benzothiazole derivative D (0.55 g,
0.78 mmol), Pd(OAc)2 (0.03 g, 0.13 mmol), and P(o-tolyl)3
(0.068 g, 0.22 mmol) were transferred to a high pressure Schlenk
tube. To this 8 mL of DMF–Et3N (5 : 1 v/v) ◦was added. The
Schlenk tube was then sealed and stirred at 90 C for 72 h. The
mixture was cooled to room temperature and filtered. The solvent
was removed under reduced pressure. The crude product was
purified by column chromatography on silica gel first using ethyl
acetate, then ethyl acetate–MeOH (4 : 1) and MeOH as eluent
to afford 1 (0.4 g, 82%) as yellow-brownish solid. 1H NMR
(500 MHz, d-DMSO) d: 8.46 (d, J = 8 Hz, 2H), 8.12 (d, J =
8 Hz, 2H), 8.06 (d, J = 8 Hz, 2H), 7.86 (t, J = 15.5 Hz, 4H),
7.65-7.42 (m, 14H), 4.52 (s, 4H), 4.03 (bt, J = 8.5 Hz, 4H), 3.73
(t, J = 5.5 Hz 4H), 3.62 -3.10 (m, 125H), 2.71 (bt, 2H), 2.43 (bt,
4H), 2.24 (bt, 2H). 13C NMR (125 MHz, d-DMSO) d: 175.99,
162.58, 156.95, 152.11, 150.64, 141.88, 140.51, 136.62, 136.06,
131.61, 129.47, 129.26, 127.91, 127.34, 127.03, 126.73, 126.29,
125.04, 124.81, 122.83, 122.67, 122.19, 122.01, 121.64, 120.77,
120.11, 119.77, 111.53, 111.24, 110.86, 79.71, 79.45, 79.18, 71.89,
71.78, 71.57, 70.97, 70.78, 70.69, 70.46, 70.39, 70.28, 70.21, 70.02,
69.97, 69.77, 69.64, 69.52, 69.47, 69.41, 69.30, 68.89, 68.53, 68.29,
Cell culture and incubation. U87MG cells were cultured in
DMEM, supplemented with 10% FBS, 1% penicillin, and 1%
streptomycin, at 37 ◦C under a 5% CO2 environment. MCF 7
cells were cultured in MEM, also supplemented with 10% FBS,
1% penicillin, and 1% streptomycin, at 37 ◦C under a 5% CO2
environment. No. 1 round 12 mm coverslips were treated with poly-
D-lysine to improve cell adhesion and washed (3¥) with PBS buffer
solution. The treated coverslips were placed in 24-well plates, and
60 000 cells/well were seeded and incubated at the same conditions
as indicated above until 75–85% confluency was reached on the
coverslips. From a 3.04 ¥ 10-4 M stock solution of probe 2 in PBS
(7.4), a series of 1, 10, and 50 mM solutions in culture media were
used to incubate both cell lines for 1 and 1.5 h. The dye solutions
were removed and the coverslipped cells were washed abundantly
with PBS (4¥).
Cell fixing and mounting. Cells were fixed with 3.7%
paraformaldehyde solution in pH = 7.4 PBS buffer for 10 min.
The fixing agent was removed and washed (2¥) with PBS. To
reduce autofluorescence, a fresh solution of NaBH4 (1 mg mL-1)
2606 | Org. Biomol. Chem., 2010, 8, 2600–2608
This journal is
The Royal Society of Chemistry 2010
©